Pluristem shares gain on stem cell therapy patent – Businessweek
|
Pluristem shares gain on stem cell therapy patent
Businessweek NEW YORK (AP) — Pluristem Therapeutics shares gained Wednesday after the Israeli company said it received an important U.S. patent that covers a stem cell therapy as a treatment for arterial disease. Pluristem said the patent covers methods for … |
